ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,050Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 70

$1.27M Total Retail Price of All Prescriptions

Rank: 6 out of 70

755 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 755 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

16% of this provider’s 755 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 21,530 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LEVOTHYROXINE SODIUM 874 801 1 2
SIMVASTATIN 759 672 2 1
FUROSEMIDE 753 698 3 6
WARFARIN SODIUM 687 621 4 10
POTASSIUM CHLORIDE 687 640 4 12
LISINOPRIL 601 584 6 3
AMLODIPINE BESYLATE 558 521 7 5
METOPROLOL TARTRATE 556 520 8 7
HYDROCODONE-ACETAMINOPHEN 544 427 S3 9 8
MIRTAZAPINE 465 462 10 20
DONEPEZIL HCL 453 445 11 11
OMEPRAZOLE 430 390 12 4
TRAMADOL HCL 371 342 13 17
NAMENDA 362 353 14 13
ZOLPIDEM TARTRATE 348 341 15 23
CITALOPRAM HBR 296 268 16 16
SERTRALINE HCL 286 268 17 22
TAMSULOSIN HCL 266 234 18 29
DIVALPROEX SODIUM 247 216 19 53
RISPERIDONE 243 186 20 32
GABAPENTIN 225 198 21 14
ATENOLOL 223 209 22 21
NOVOLOG 206 179 23 56
ALENDRONATE SODIUM 199 145 24 28
LOSARTAN POTASSIUM 193 189 25 24
ATORVASTATIN CALCIUM 188 168 26 27
LEVETIRACETAM 182 157 27 59
METFORMIN HCL 180 159 28 9
ESCITALOPRAM OXALATE 180 152 28 35
CARVEDILOL 178 157 30 19
TRAZODONE HCL 175 148 31 36
OXYCODONE-ACETAMINOPHEN 173 171 S2 32 64
HYDROCHLOROTHIAZIDE 170 163 33 15
FAMOTIDINE 168 137 34 73
BACLOFEN 163 146 35 98
CLOPIDOGREL 150 145 36 30
MELOXICAM 149 137 37 39
OXYBUTYNIN CHLORIDE ER 146 123 38 86
FINASTERIDE 141 139 39 75
ALLOPURINOL 139 137 40 31
LANTUS 134 83 41 38
CIPROFLOXACIN HCL 126 118 42 51
GLUCAGEN 123 98 43 188
PREDNISONE 120 102 44 52
GLIMEPIRIDE 115 95 45 34
RANITIDINE HCL 114 112 46 26
QUETIAPINE FUMARATE 112 98 47 37
DIGOXIN 112 109 47 41
PLAVIX 109 103 49 43
CLONIDINE HCL 109 86 49 46
ALBUTEROL SULFATE 109 100 49 97
CEFTRIAXONE 107 100 52 144
LEVOFLOXACIN 105 95 53 71
VANCOMYCIN HCL 103 98 54 246
SPIRONOLACTONE 102 95 55 61
AZITHROMYCIN 102 89 55 40
IPRATROPIUM-ALBUTEROL 100 96 57 69
FLUTICASONE PROPIONATE 100 75 57 47
NITROFURANTOIN MONO-MACRO 100 96 57 171
ROPINIROLE HCL 100 100 57 106
PRAVASTATIN SODIUM 98 97 61 18
METOPROLOL SUCCINATE 98 84 61 25
KLOR-CON M20 95 90 63 79
PROMETHAZINE HCL 94 81 R 64 110
PANTOPRAZOLE SODIUM 93 84 65 42
LOVASTATIN 91 78 66 33
ADVAIR DISKUS 88 69 67 55
GENERLAC 86 85 68 201
CEPHALEXIN 85 76 69 123
CYMBALTA 82 78 70 67
HYDROXYZINE HCL 81 68 R 71 182
POLYETHYLENE GLYCOL 3350 81 76 71 84
LYRICA 79 79 73 90
LIDODERM 79 77 73 93
DIVALPROEX SODIUM ER 79 49 73 158
CHOLESTYRAMINE 76 74 76 267
LEVEMIR 75 63 77 126
AMIODARONE HCL 74 74 78 183
CRESTOR 71 67 79 45
TRIAMCINOLONE ACETONIDE 71 58 79 146
METOCLOPRAMIDE HCL 71 71 79 131
SANTYL 71 70 79 130
CLOTRIMAZOLE-BETAMETHASONE 70 58 83 151
DOXYCYCLINE HYCLATE 69 62 84 105
GLIPIZIDE 69 69 84 48
CYCLOBENZAPRINE HCL 69 29 R 84 103
LIDOCAINE HCL 69 67 84 207
NYSTATIN-TRIAMCINOLONE 68 56 88 221
CARBIDOPA-LEVODOPA 67 67 89 70
DILTIAZEM HCL 66 63 90 208
KLOR-CON M10 65 63 91 133
SEROQUEL 64 64 92 87
NYSTATIN 63 59 93 124
METOLAZONE 62 48 94 229
BRIMONIDINE TARTRATE 61 61 95 236
METHYLPREDNISOLONE 60 52 96 103
GLYBURIDE 58 50 R 97 74
PAROXETINE HCL 58 27 97 66
ABILIFY 56 34 99 100
VENLAFAXINE HCL ER 55 55 100 147
MUPIROCIN 55 52 100 68
DILTIAZEM ER 54 54 102 189
BUMETANIDE 54 54 102 109
NEXIUM 53 42 104 63
ISOSORBIDE MONONITRATE ER 52 52 105 50
VERAPAMIL ER 52 43 105 134
LEXAPRO 52 47 105 99
ENALAPRIL MALEATE 52 39 105 54
PROAIR HFA 51 31 109 80
ENULOSE 51 51 109 306
LATANOPROST 50 39 111 190
OXYCODONE HCL 50 48 S2 111 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.